CVS Health (CVS) stock tumbles as earnings, guidance miss expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE
May 1, 2024 6:30 AM EDTFirst Quarter Highlights
Total revenues increased to $88.4 billion, up 3.7% compared to prior yearGAAP diluted EPS of $0.88 and Adjusted EPS of $1.31Generated cash flow from operations of $4.9 billion2024 Full-Year Guidance
Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06Revised Adjusted EPS guidance to at least $7.00 from at least $8.30Revised cash flow from operations guidance to at least $10.5 billion... More